Retrospective Study on Caplacizumab-treated Pediatric Patients With Immune-mediated Thrombocytopenic Purpura (iTTP)
Clinical trial NCT05263193 · COMPLETED
Trial details
- NCT number
- NCT05263193
- Sponsor
- Sanofi
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-06-08
- Primary completion
- 2022-10-28
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.